TLM Utility Nav

Hepatitis B – Improving Care by Addressing Stigma

Description

We will examine the effects of stigma and discrimination on patient outcomes and review successful intervention in populations at risk for discrimination. Learn about the patient experience, HBV guidelines, outreach, and clinical practice efforts to reduce stigma and discrimination. This session includes an abstract tour and is developed by AASLD's Patient Advisory Group. 
 

Presentations

2:00 PM - 2:15 PM
Nov 16 2024
San Diego, CA

Why Stigma and Discrimination Matter? The Patient Experience

Monue D Flomo, Bachelor of Science in Biology, Presenter
Hepatitis
Liver Cancer
Patient Program
2:15 PM - 2:30 PM
Nov 16 2024
San Diego, CA

Do HBV Guidelines help to Combat Stigma/Discrimination?

Marc Ghany, MD, MHSc, FAASLD, Presenter
Hepatitis
Liver Cancer
Patient Program
2:30 PM - 2:45 PM
Nov 16 2024
San Diego, CA

Outreach and Clinical Practice Changes to Reduce Discrimination/Stigma

Y. Tony Yang, Presenter
Hepatitis
Liver Cancer
Patient Program
2:45 PM - 3:00 PM
Nov 16 2024
San Diego, CA

Panel Discussion

Su H Wang, MD MPH FACP, Presenter
Hepatitis
Liver Cancer
Patient Program
3:00 PM - 3:20 PM
Nov 16 2024
San Diego, CA

Abstract Tour

Robert Wong, MD, MS, FAASLD, Presenter
Hepatitis
Liver Cancer
Patient Program

Objectives

  • Examine the effects of stigma and discrimination on HBV outcomes
  • Consider have HBV guidelines may help to combat stigma
  • Review successful interventions in populations at risk for discrimination
Chair

Bright Ansah

Chair

Norah Terrault, MD, MPH, FAASLD

University of Southern California